A world first school-based physical activity program tailored to adolescents is improving the cardiorespiratory fitness and wellbeing of young people by supporting their engagement in short high intensity interval workouts.
Pancreatic cancer is the fourth most common cause of death from cancer. Researchers at the Garvan Institute of Medical Research have tested a new drug that directly targets aggressive pancreatic tumours which could improve patient outcomes.
Luminesce Alliance invites you to submit an abstract to support the 2024 Conference theme 'Paediatric Precision Medicine: Advancing research and patient care.' Early bird registrations are also open for the event on 7-8 November.
'Diagnostic Odyssey' is a term that describes the long and difficult journey a patient endures to receive an accurate diagnosis. Patients who embark on a diagnostic odyssey usually have a rare disease and rare diseases often affect multiple organs.
The Medical Research Support Program is the NSW Government's flagship infrastructure funding program for eligible independent medical research institutes across NSW. The program provides support for the indirect costs of research based on success in competitive National Health and Medical Research Council grant schemes.
NSW Health's Software as a Medical Device Specialisation course will help you navigate the market and regulatory landscapes for Software as a Medical Device (SAMD) products, develop skills in capital raising and crafting a robust go-to-market strategy and pitch deck. The course is run as part of NSW Health’s Commercialisation Training Course.
The 2024 round of NSW Health's Senior and Early-Mid Career Researcher Grants is open for applications. A recording of the workshop held on 9 May will be uploaded shortly. The workshop provided advice on how to write a successful application. Videos from last year’s workshop can also be accessed here.
Through the NSW Health Clinical Innovation and Research Division, the Office for Health and Medical Research works with research communities, universities and business to promote growth and innovation in health and medical research to achieve better outcomes for patients and establish NSW as a global centre of excellence.
